Nearly 1 in 100 Canadians Now Has IBD, and the Numbers Are Still Climbing

If your gut has been acting up and you've caught yourself wondering whether it's just stress or something more chronic, the latest numbers out of Canada are worth knowing. A national surveillance analysis from the Canadian Gastrointestinal Epidemiology Consortium (CanGIEC) finds that inflammatory bowel disease, or IBD (a group of chronic conditions, chiefly Crohn's disease and ulcerative colitis, in which the immune system attacks the lining of the digestive tract) now affects nearly 1 in every 100 Canadians, and the number keeps climbing. The 2023 Impact of IBD in Canada report, published in the Journal of the Canadian Association of Gastroenterology, lays out how fast, and who is being hit hardest.

Key takeaways

• IBD now affects an estimated 322,600 Canadians (0.82% of the population), projected to reach 470,000 people, or about 1 in 91, by 2035.
• The fastest growth is in children: pediatric-onset IBD incidence is rising 1.23% a year, while rates in adults and seniors have stayed essentially flat.
• The disease keeps accumulating because new diagnoses (about 11,700 in 2023) far outpace deaths from it, a pattern researchers call "compounding prevalence."
• The 2035 figures are trend-based forecasts, not confirmed outcomes, and the picture varies a lot province to province.

IBD Prevalence in Canada Has More Than Doubled Since 2002

In 2023, an estimated 825 per 100,000 Canadians, or roughly 322,600 people, are living with IBD, more than double the 389-per-100,000 rate recorded in 2002 and up from 636 per 100,000 in 2014. CanGIEC built this estimate by pooling provincial health-surveillance data and modeling the trend forward: prevalence has been rising by about 2.44% a year since 2014, and if that continues, it will reach 1.08% of the population, or 470,000 Canadians, by 2035. Split by disease, the current burden is nearly even between Crohn's disease and ulcerative colitis. Provincial rates for 2023 range from 720 per 100,000 in Manitoba up to 968 per 100,000 in Alberta, so the "1 in 100" figure is a national average, not a uniform rate everywhere.

Children Are Driving the Fastest Growth in New Diagnoses

The overall incidence of IBD (the rate of brand-new diagnoses each year) was 30 per 100,000 person-years in 2023, translating to more than 11,700 Canadians newly diagnosed that year, about 4,800 with Crohn's disease and 6,800 with ulcerative colitis or IBD-unclassified. What stands out is where that growth is concentrated: pediatric-onset incidence climbed from 13.9 per 100,000 in 2014 and is forecast to keep rising 1.23% a year to 18.0 per 100,000 by 2035, while incidence among adults and seniors over 64 has stayed essentially stable. Overall national incidence is forecast to reach 32.1 per 100,000 by 2035, representing about 14,000 new diagnoses a year.

Six Provinces of Health-System Data Built This Estimate

This isn't a survey or a small clinical sample. CanGIEC, a national network of IBD epidemiologists, drew on provincial administrative healthcare databases from six provinces (British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec) covering more than 95% of the Canadian population. Coverage years differ by province (most run from roughly 2002 to 2014, Manitoba's data reaches back to 1987, and British Columbia's extends to 2019), and researchers used the overlapping years to build a national model, calculate each province's average annual rate of change, and forecast prevalence and incidence out to 2035.

What the Rising Numbers Mean if You Suspect Gut Trouble

If you're dealing with persistent belly pain, diarrhea, rectal bleeding, ongoing fatigue, or unexplained weight loss, those are the kinds of symptoms worth raising with a doctor, since they overlap with IBD's hallmark presentation. This report doesn't establish a way to prevent IBD, but it does point to what researchers currently think is reasonable, if unproven, guidance: minimizing smoking and high-dose NSAID use, eating a whole-food, Mediterranean-style diet rich in vegetables, fruit, and fish oils while limiting red and processed meat and highly processed foods, staying physically active, and maintaining a healthy weight. None of that is a guarantee, and the researchers are explicit that this guidance comes from observational cohort studies, not randomized trials.

The Forecasts Rest on Real Limitations

The headline 2035 numbers, 470,000 people and 14,000 new diagnoses a year, are model-based projections built on the assumption that current trends continue, not something that has already happened. Provincial trends underneath the national average are also inconsistent: incidence was rising in British Columbia and Quebec, roughly stable in Alberta and Ontario, and declining in Manitoba and Saskatchewan, though the Saskatchewan estimate carries a very wide confidence interval. Data on Indigenous populations and first-generation immigrants remain sparse. It's also worth noting this report was published as part of a supplement sponsored by Crohn's and Colitis Canada, a patient advocacy charity, with additional support from a Canadian Institutes of Health Research grant.

Researchers Are Now Hunting for IBD's Early Warning Signs

One active line of work is the CCC-GEM project (Genetic, Environmental, Microbial project), a prospective cohort that has followed more than 5,000 first-degree relatives of people with Crohn's disease since 2008, more than 120 of whom have since been diagnosed themselves. By tracking people before they get sick, researchers have found that certain antibodies to gut microbes and changes in intestinal permeability show up before a clinical diagnosis, and that a subset of participants who adopted a Mediterranean diet showed microbiome shifts linked to reduced gut inflammation ahead of any diagnosis. Future studies are expected to dig into which specific environmental exposures are driving the pediatric-incidence gap.

Common Questions

What is inflammatory bowel disease, and how is it different from IBS? IBD (Crohn's disease and ulcerative colitis) involves actual immune-driven inflammation and tissue damage in the digestive tract, detectable on imaging or biopsy, while irritable bowel syndrome (IBS) is a functional disorder without that visible inflammation.

Why is IBD incidence rising fastest in children? Researchers don't fully know yet. The report notes pediatric-onset incidence is climbing about 1.23% a year while adult and senior rates are flat, and flags this gap as a priority for future research into early-life environmental exposures.

Can diet or lifestyle changes prevent IBD? Not proven, but there's suggestive evidence. Whole-food, Mediterranean-style diets and avoiding smoking are associated with lower risk and better disease control in observational studies, though randomized controlled trials confirming prevention are still lacking.

Is IBD more common in specific populations in Canada? Historically it was considered most common among Caucasians of European descent, but current data show rising incidence among Indigenous populations and first-generation children of immigrants, including those of South Asian descent, whose incidence is now similar to the general population.

References

1. Stephanie Coward, Eric I Benchimol, M Ellen Kuenzig, et al. (2023). The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD. Journal of the Canadian Association of Gastroenterology. https://doi.org/10.1093/jcag/gwad004
2. Journal of the Canadian Association of Gastroenterology, primary report. academic.oup.com. https://academic.oup.com/jcag/article/6/Supplement_2/S9/7260539